SCHEMBL6981045

SCHEMBL6981045

CNc1cc(N2CCC(C(=O)N3CCN(S(=O)(=O)c4ccc(C(F)(F)F)cc4)CC3)CC2)ncn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LSS P48449 4/20 0.54
CCR6 P51684 2/20 0.49
CNR1 P21554 3/20 0.49
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
EPHX2 P34913 1/20 0.45
PKM P14618 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980671 0.96 CCR6 (0.51) LSSCCR6CNR1ALDH1A1KDM4E
SCHEMBL7085163 0.88 LSS (0.69) LSSCNR1ALDH1A1L3MBTL1NPC1
SCHEMBL6978885 0.88 ALDH1A1 (0.54) CCR6CNR1ALDH1A1KDM4EMAPT
SCHEMBL6970581 0.86 LSS (0.56) LSSCNR1ALDH1A1KDM4EMAPT
SCHEMBL6978502 0.83 LSS (0.52) LSSCCR6CNR1KDM4EMAPT
SCHEMBL7654951 0.76 LSS (0.72) LSSCNR1ALDH1A1MAPTL3MBTL1
SCHEMBL6980850 0.76 LSS (0.61) LSSCNR1ALDH1A1NPC1RAB9A
SCHEMBL6977047 0.76 LSS (0.51) LSSALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL26429307 0.75 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTL3MBTL1EPHX2
SCHEMBL6979430 0.74 LSS (0.72) LSSCNR1ALDH1A1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0925286-B1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ASTRAZENECA AB (SE) 2003-01-02 EP disclosed
US-6093718-A AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS ZENECA LIMITED (GB) 2000-07-25 US disclosed
EP-0925286-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ZENECA LIMITED (GB) 1999-06-30 EP disclosed
WO-1998006705-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ZENECA LIMITED (GB) 1998-02-19 WO disclosed